Literature DB >> 2210060

Absence of brown product FFI in nondiabetic and diabetic rat collagen.

A Lapolla1, C Gerhardinger, B Pelli, A Sturaro, E Del Favero, P Traldi, G Crepaldi, D Fedele.   

Abstract

Accumulation of brown products in long-lived proteins might be an important factor in determining long-term diabetic complications. Fluorescent chromophore 2-(2-furoyl)-4-(5)-(2-furanyl)-1H-imidazole (FFI), isolated from hydrolyzed brown products synthesized in vitro, was proposed as a specific brown product responsible for functional and structural changes in long-lived proteins. In this study, an attempt was made to demonstrate by means of collision spectroscopy the presence of FFI in collagen samples taken from diabetic rats. Diabetic rat collagen samples showed mean values of absorbance per milligram of 4-hydroxy-L-proline significantly higher than those observed in nondiabetic rats, suggesting higher FFI levels. Surprisingly, all collagen samples from diabetic and nondiabetic rats gave collision spectra in which no peak diagnostic of FFI presence was observed. These data suggest that the absorbance level observed in diabetic rats is not due to the presence of FFI but to structurally related compounds, which are being investigated by means of mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210060     DOI: 10.2337/diacare.39.1.57

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Studies on advanced glycation end products by recent mass spectrometric techniques.

Authors:  A Lapolla; D Fedele; P Traldi
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

2.  A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects.

Authors:  A Lapolla; D Fedele; R Seraglia; S Catinella; L Baldo; R Aronica; P Traldi
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

Review 3.  Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update.

Authors:  Francesco Piarulli; Giovanni Sartore; Annunziata Lapolla
Journal:  Acta Diabetol       Date:  2012-07-05       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.